Background: Moral distress arises when a person is aware of the right course to take but is prevented from acting on it by institutional constraints. While this concept has been considered by nursing ethicists for many years, it has been particularly associated with the unprecedented healthcare conditions caused by the coronavirus disease 2019 (COVID-19) pandemic.
Aim: To investigate the level of moral distress affecting advanced practice nurses (APNs) in the UK during the COVID-19 pandemic.
Method: This was a mixed-methods study in which a bespoke cross-sectional survey was sent to 243 APNs from across the UK who had been recruited to a broader longitudinal cohort study. The survey asked about their experiences, well-being and moral distress. Open-ended questions asked about their concerns regarding the health and well-being of their patients and colleagues.
Findings: A total of 97 APNs completed the survey, yielding a 40% response rate. Levels of moral distress were significantly higher among APNs working in secondary care (P=0.026) compared with those working in primary care. All of the respondents expressed concerns about patients due to delayed care and about the mental well-being of their colleagues, particularly those who were redeployed to COVID-19 wards.
Conclusion: The COVID-19 pandemic has caused moral and psychological distress for APNs. However, the type of distress and its direct causes varied among these practitioners. Tailored support is required to address moral distress and subsequently improve staff retention.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.7748/ns.2022.e11885 | DOI Listing |
Eur J Investig Health Psychol Educ
December 2024
Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool L69 7ZA, UK.
The first 16 weeks postpartum are particularly challenging for a new mother and are associated with an elevated risk of experiencing psychological distress. Guilt and shame have been identified as significant predictors of other forms of psychological distress, such as anxiety and depression. However, guilt and shame are poorly distinguished in pre-existing literature.
View Article and Find Full Text PDFActa Paediatr
December 2024
Department of Neonatal Medicine, Cochin Port Royal hospital FHU Prema, Paris, France.
Aim: Healthcare givers are exposed to stress and therefore are at risk of the development of pathologies. We aimed to provide recommendations regarding psychosocial risks such as stress, moral distress, burnout syndrome or secondary stress syndrome in neonatal care units to best support neonatal healthcare givers.
Methods: We searched PubMed for articles published from 1 January 2017 to 1 December 2023 by using the keywords burnout OR (moral and distress) AND neonatal unit.
J Am Board Fam Med
December 2024
From the University of Colorado, School of Medicine, Aurora, CO (TF, CR, CK, JC, PST, MK, AM); Division of General Internal Medicine, Department of Medicine, University of Colorado Anschutz, Medical Campus, Aurora, CO (TF); Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO (CR, CK, JC, MK); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO (PST); Division of Hospital Medicine, Department of Medicine, University of Colorado Anschutz Medical, Campus, Aurora, CO (AM); Veterans' Health Administration, Eastern CO Health Care System, Aurora, CO (AM).
Background: Physician burnout contributes to distress, turnover, and poor patient outcomes. Evidence suggests individual professional coaching may mitigate burnout but is costly and time intensive. Group coaching evidence is lacking.
View Article and Find Full Text PDFInt J Nanomedicine
December 2024
Department of Immunology, Oncology and Nanobiomedicine Initiative, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.
Background: Severe Acute Respiratory syndrome coronavirus 2 (SARS-CoV-2) and Influenza A viruses (IAVs) are among the most important causes of viral respiratory tract infections, causing similar symptoms. IAV and SARS-CoV-2 infections can provoke mild symptoms like fever, cough, sore throat, loss of taste or smell, or they may cause more severe consequences leading to pneumonia, acute respiratory distress syndrome or even death. While treatments for IAV and SARS-CoV-2 infection are available, IAV antivirals often target viral proteins facilitating the emergence of drug-resistant viral variants.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!